Shuping Yin

825 total citations
16 papers, 664 citations indexed

About

Shuping Yin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shuping Yin has authored 16 papers receiving a total of 664 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Shuping Yin's work include Cell death mechanisms and regulation (4 papers), Protease and Inhibitor Mechanisms (4 papers) and Cancer Cells and Metastasis (3 papers). Shuping Yin is often cited by papers focused on Cell death mechanisms and regulation (4 papers), Protease and Inhibitor Mechanisms (4 papers) and Cancer Cells and Metastasis (3 papers). Shuping Yin collaborates with scholars based in United States, China and Russia. Shuping Yin's co-authors include Shijie Sheng, Xiaohua Li, Kaladhar B. Reddy, Neelima Reddy, Fazlul H. Sarkar, Liping Xu, Wael Sakr, Jaron Lockett, Yonghong Meng and Jiayou Liu and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Shuping Yin

16 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shuping Yin United States	11	438	294	217	60	53	16	664
Heidi Y. Shi United States	14	371 0.8×	289 1.0×	192 0.9×	90 1.5×	50 0.9×	19	685
Xiaoyi Mi China	17	596 1.4×	254 0.9×	244 1.1×	22 0.4×	44 0.8×	42	768
Frank Rösel Germany	8	247 0.6×	185 0.6×	150 0.7×	53 0.9×	20 0.4×	12	440
Quanhong Sun United States	16	599 1.4×	164 0.6×	264 1.2×	30 0.5×	65 1.2×	28	936
Arulselvi Anbalagan United States	8	222 0.5×	175 0.6×	203 0.9×	25 0.4×	74 1.4×	10	486
Sun Joo Lee South Korea	11	254 0.6×	135 0.5×	103 0.5×	27 0.5×	69 1.3×	14	433
Gonzalo Lopez United States	15	505 1.2×	201 0.7×	160 0.7×	37 0.6×	27 0.5×	21	721
Aino Paasinen-Sohns Finland	10	323 0.7×	138 0.5×	153 0.7×	16 0.3×	63 1.2×	13	517
Meng‐Huee Lee United Kingdom	16	266 0.6×	391 1.3×	323 1.5×	25 0.4×	35 0.7×	20	636
Jonathan Waxman United Kingdom	7	311 0.7×	269 0.9×	257 1.2×	21 0.3×	65 1.2×	17	633

Countries citing papers authored by Shuping Yin

Since Specialization

Citations

This map shows the geographic impact of Shuping Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuping Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuping Yin more than expected).

Fields of papers citing papers by Shuping Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuping Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuping Yin. The network helps show where Shuping Yin may publish in the future.

Co-authorship network of co-authors of Shuping Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Shuping Yin. A scholar is included among the top collaborators of Shuping Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuping Yin. Shuping Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Yin, Shuping, Han Cui, Shuang Qin, & Shengnan Yu. (2023). Manipulating TGF-β signaling to optimize immunotherapy for cervical cancer. Biomedicine & Pharmacotherapy. 166. 115355–115355. 7 indexed citations

He, Xiangqin, Fang Liu, Shuping Yin, et al.. (2020). YY1 directly interacts with myocardin to repress the triad myocardin/SRF/CArG box-mediated smooth muscle gene transcription during smooth muscle phenotypic modulation. Scientific Reports. 10(1). 21781–21781. 10 indexed citations

Yin, Shuping, et al.. (2017). Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells. PLoS ONE. 12(8). e0183578–e0183578. 66 indexed citations

Ahmad, Aamir, Kevin R. Ginnebaugh, Shuping Yin, et al.. (2015). Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4. BMC Cancer. 15(1). 540–540. 69 indexed citations

Yin, Shuping, Vino T. Cheriyan, Arun K. Rishi, & Kaladhar B. Reddy. (2015). Abstract 2225: c-Myc and Frizzled 8 play a major role in the regulation of cancer stem cells and drug resistance in triple-negative breast cancer. Cancer Research. 75(15_Supplement). 2225–2225. 2 indexed citations

Yin, Shuping, Arun K. Rishi, & Kaladhar B. Reddy. (2015). Anti-estrogen-resistant breast cancer cells are sensitive to cisplatin plus TRAIL treatment. Oncology Reports. 33(3). 1475–1480. 8 indexed citations

Yin, Shuping, Liping Xu, R. Daniel Bonfil, et al.. (2013). Tumor-Initiating Cells and FZD8 Play a Major Role in Drug Resistance in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics. 12(4). 491–498. 54 indexed citations

Reddy, Kaladhar B., et al.. (2013). Abstract 241: Tumor initiating cells and FZD8 play a major role in drugresistance and tumor progression in triple negative breast cancer.. Cancer Research. 73(8_Supplement). 241–241. 1 indexed citations

Xu, Liping, Shuping Yin, Sanjeev Banerjee, Fazlul H. Sarkar, & Kaladhar B. Reddy. (2011). Enhanced Anticancer Effect of the Combination of Cisplatin and TRAIL in Triple-Negative Breast Tumor Cells. Molecular Cancer Therapeutics. 10(3). 550–557. 31 indexed citations

10.

Yin, Shuping, Seema Sethi, & Kaladhar B. Reddy. (2010). Protein kinase Cδ and caspase‐3 modulate TRAIL‐induced apoptosis in breast tumor cells. Journal of Cellular Biochemistry. 111(4). 979–987. 7 indexed citations

11.

Li, Xiaohua, Di Chen, Shuping Yin, et al.. (2007). Maspin augments proteasome inhibitor‐induced apoptosis in prostate cancer cells. Journal of Cellular Physiology. 212(2). 298–306. 32 indexed citations

12.

Yin, Shuping, Jaron Lockett, Yonghong Meng, et al.. (2006). Maspin Retards Cell Detachment via a Novel Interaction with the Urokinase-Type Plasminogen Activator/Urokinase-Type Plasminogen Activator Receptor System. Cancer Research. 66(8). 4173–4181. 63 indexed citations

13.

Li, Xiaohua, Shuping Yin, Yonghong Meng, Wael Sakr, & Shijie Sheng. (2006). Endogenous Inhibition of Histone Deacetylase 1 by Tumor-Suppressive Maspin. Cancer Research. 66(18). 9323–9329. 68 indexed citations

14.

Lockett, Jaron, Shuping Yin, Xiaohua Li, Yonghong Meng, & Shijie Sheng. (2005). Tumor suppressive maspin and epithelial homeostasis. Journal of Cellular Biochemistry. 97(4). 651–660. 79 indexed citations

15.

Yin, Shuping, Xiaohua Li, Yonghong Meng, et al.. (2005). Tumor-suppressive Maspin Regulates Cell Response to Oxidative Stress by Direct Interaction with Glutathione S-Transferase. Journal of Biological Chemistry. 280(41). 34985–34996. 70 indexed citations

16.

Liu, Jiayou, et al.. (2004). Bax Mediates the Apoptosis-Sensitizing Effect of Maspin. Cancer Research. 64(5). 1703–1711. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact